FindMyKOL
Clinical trialNCT07890922Not, yet, recruitingInterventional

AI-Assisted Systemic Health Risk Assessment in General Ophthalmology

NCT07890922 is an interventional trial sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. As of 18 Nov 2026, it is not yet recruiting. It studies Systemic Health Risk. The registry lists an enrollment of 2,000 participants at 1 site in 1 country. The registry lists a start date of 19 Oct 2026 and a primary completion date of 19 Feb 2027. One of its registered investigators has a FindMyKOL profile.

SponsorZhongshan Ophthalmic Center, Sun Yat-sen UniversityEnrollment2,000Systemic Health Risk
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07890922
FieldValue
Registry IDNCT07890922
StatusNot yet recruiting
Study typeInterventional trial
Lead sponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment2,000
Registered sites1
Countries1
ConditionsSystemic Health Risk
Start19 Oct 2026
Primary completion19 Feb 2027
Study completion28 Feb 2027
Last update posted28 Oct 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate whether providing ophthalmologists with additional artificial intelligence (AI)-assisted health risk information derived from routine retinal images affects subsequent clinical care in adults attending general ophthalmology clinics. Participating ophthalmologists will be assigned to either usual ophthalmic care or usual ophthalmic care with access to supplementary information generated by an AI system. The AI system does not independently diagnose disease or determine treatment. All clinical decisions remain the responsibility of the ophthalmologist. Participants will receive routine ophthalmic care and will be followed after the ophthalmology visit to collect information on subsequent medical evaluation, newly identified systemic conditions, and changes in clinical management.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China1 site
  • Zhongshan Ophthalmic Center, Sun Yat-Sen University

    Guangzhou, Guangdong

Sites by country

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07890922

Each answer restates registry values shown on this page.

What is NCT07890922?

NCT07890922 is an interventional trial sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. It studies Systemic Health Risk.

Is NCT07890922 recruiting?

As of 18 Nov 2026, it is not yet recruiting.

Who leads NCT07890922?

The registry names Wei Wang, PhD (principal investigator, Zhongshan Ophthalmic Center, Sun Yat-sen University) as the overall official.

Where does NCT07890922 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: China.

When is NCT07890922 expected to complete?

The registry lists a primary completion date of 19 Feb 2027 and a study completion date of 28 Feb 2027. The sponsor last updated the record on 28 Oct 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.